-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, M0nwuTRZk/aaG+S7a0WfBB8rXJpjDWYXGASSMdWoR6P2bpSbK0+nK/huYemX+0Xb ungKFl9EW3NE/tuC8u8VwA== 0001144204-10-000966.txt : 20100107 0001144204-10-000966.hdr.sgml : 20100107 20100107165456 ACCESSION NUMBER: 0001144204-10-000966 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20091231 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20100107 DATE AS OF CHANGE: 20100107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOANALYTICAL SYSTEMS INC CENTRAL INDEX KEY: 0000720154 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 351345024 STATE OF INCORPORATION: IN FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-23357 FILM NUMBER: 10515329 BUSINESS ADDRESS: STREET 1: 2701 KENT AVE CITY: WEST LAFAYETT STATE: IN ZIP: 47906-1382 BUSINESS PHONE: 3174634527 MAIL ADDRESS: STREET 1: 2701 KENT AVENUE CITY: WEST LAFAYETTE STATE: IN ZIP: 47906-1382 8-K 1 v170810_8k.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 31, 2009

BIOANALYTICAL SYSTEMS, INC. 

(Exact name of registrant as specified in its charter)

Indiana
 
0-23357
 
35-1345024
(State or other jurisdiction
of incorporation or
organization)
 
(Commission File Number)
 
(I.R.S. Employer Identification
No.)

2701 KENT AVENUE
WEST LAFAYETTE, INDIANA
 
47906-1382
(Address of principal executive offices)
 
(Zip Code)

Registrant's telephone number, including area code: (765) 463-4527

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act(17CFR240.14a-12)

o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act(17CFR240.14d-2(b))

o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act(17CFR240.13e-4(c))
 
 
 

 

Item 1.01. Entry into a Material Definitive Agreement
 
On December 31, 2009, Bioanalytical Systems, Inc. (“BASi”) and PNC Bank, as successor by merger to National City Bank (“PNC”) executed a Fifth Amendment to the Amended and Restated Credit Agreement (the “Credit Agreement”) (collectively, the “Credit Facility”).
 
The Credit Facility may be drawn up to a maximum aggregate principal amount of the lesser of $3,000,000 or the “Borrowing Base” of Bioanalytical Systems, Inc. (as defined in the Credit Agreement).   Interest on the outstanding balance of advances is payable on the last day of each calendar month with respect to each Prime Rate Advance (as defined in the Credit Agreement). The entire principal balance of advances together with all accrued and unpaid interest, and all fees and charges are due upon the maturity date.
 
Under the amended Credit Facility (i) the maturity date of the line of credit was extended from December 31, 2009 to January 15, 2010 and (ii) the interest prior to maturity or default on outstanding principal balance of advances was changed to a per annum rate equal to the LIBOR plus nine percent (9%), and in the event the LIBOR becomes unavailable, the interest rate will be the Prime Rate plus six percent (6%). In addition, BAS Evansville, Inc., a subsidiary of BASi, executed a Reaffirmation of Replacement Subsidiary Guaranty to guaranty BASi's obligations under the Credit Facility.
 
The foregoing discussion of the Credit Facility is entirely qualified by reference to the Credit Agreement, which is attached as Exhibit 10.1, and incorporated herein by this reference.
 
Item 2.03. Creation of a Direct Financial Obligation or an Obligation Under and Off-Balance Sheet Arrangement of a Registrant.
 
The information provided in Item 1.01 of this Current Report on Form 8-K is incorporated into this Item 2.03 by reference.
 
Item 9.01. Financial Statements and Exhibits.
 
(a) Not applicable.
 
(b) Not applicable.
 
(c) Not applicable.
 
(d) Exhibits:
 
10.1 
Fifth Amendment to Amended and Restated Credit Agreement between Bioanalytical Systems, Inc. and PNC Bank, as successor to National City Bank, executed December 31, 2009.

 
 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
BIOANALYTICAL SYSTEMS, INC.
     
Date: December 31, 2009
By:
/s/ Michael R. Cox 
 
   
Michael R. Cox
   
Vice President, Finance and Administration,
   
Chief Financial Officer and Treasurer

 
 

 
 
Exhibit Index
 
Exhibit No.
 
Description
     
10.1
 
Fifth Amendment to Amended and Restated Credit Agreement between Bioanalytical Systems, Inc. and PNC Bank, as successor to National City Bank, executed December 31, 2009.
 
 
 

 
EX-10.1 2 v170810_ex10-1.htm
Fifth Amendment To
Amended and Restated Credit Agreement

This Fifth Amendment to Amended and Restated Credit Agreement (this “Fifth Amendment”) dated as of the 31st day of December, 2009, is by and between Bioanalytical Systems, Inc. (“Borrower”) and PNC Bank, National Association, as successor by merger to National City Bank (“Bank”);

Witnesseth:

Whereas, as of January 4, 2005, the parties hereto entered into a certain Credit Agreement, as amended (as amended, the “Agreement”);
 
Whereas, the parties desire to further amend the Agreement, subject to the terms contained therein;
 
Now, Therefore, in consideration of the premises, and the mutual promises herein contained, the parties agree that the Agreement shall be, and it hereby is, amended as provided herein and the parties further agree as follows:

Part I.  Amendatory Provisions

Article 1.  Definition

Section 1.1 of the Agreement is hereby amended by substituting the following definition in lieu of the like existing definition:
 
Line of Credit Maturity Date” means January 15, 2010.

Article 2.  Credit

2.2          Interest; Unused Fees and Rate Selection.

2.2.1.  Line of Credit - Interest.  Section 2.2.1 of the Agreement is hereby amended by substituting the following new Section 2.2.1 in lieu of the existing Section 2.2.1:
 
2.2.1 Line of Credit - Interest.  Prior to maturity or Default, the outstanding principal balance of Advances under the Line of Credit shall bear interest at a per annum rate equal to the LIBOR plus Nine Percent (9%).  In the event that the LIBOR shall become unavailable, the outstanding principal balance of Advances under the Line of Credit shall bear interest at a per annum rate equal to the Prime Rate plus Six Percent (6%).
   
Fifth Amendment to Amended and Restated Credit Agreement
Page  1
 
 
 

 
 
Part II.  Continuing Effect

Except as expressly modified herein:
 
(a)           All terms, conditions, representations, warranties and covenants contained in the Agreement shall remain the same and shall continue in full force and effect, interpreted, wherever possible, in a manner consistent with this Fifth Amendment; provided, however, in the event of any irreconcilable inconsistency, this Fifth Amendment shall control;
 
(b)           The representations and warranties contained in the Agreement shall survive this Fifth Amendment in their original form as continuing representations and warranties of Borrower; and
 
(c)           Capitalized terms used in writing by Bank, and not specifically herein defined, shall have the meanings ascribed to them in the Agreement.
 
In consideration hereof, Borrower represents, warrants, covenants and agrees that:
 
(aa)         Each representation and warranty set forth in the Agreement, as hereby amended, remains true and correct as of the date hereof in all material respects, except to the extent that such representation and warranty is expressly intended to apply solely to an earlier date and except changes reflecting transactions permitted by the Agreement;
 
(bb)         There currently exist no offsets, counterclaims or defenses to the performance of the Obligations (such offsets, counterclaims or defenses, if any, being hereby expressly waived);
 
(cc)         Except as expressly waived in writing by Bank, there has not occurred any Default or Unmatured Default; and
 
(dd)         After giving effect to this Fifth Amendment and any transactions contemplated hereby, no Default or Unmatured Default is or will be occasioned hereby or thereby.
 
Part III.  Conditions Precedent

Notwithstanding anything contained in this Fifth Amendment to the contrary, Bank shall have no obligation under this Fifth Amendment until each of the following conditions precedent have been fulfilled to the satisfaction of Bank:
 
(a)           Bank shall have received this Fifth Amendment, duly executed in the form prescribed by Bank;
 
(b)           Bank shall have received a Reaffirmation of Guaranty, in the form prescribed by Bank, duly executed by each Guarantor;
   
Fifth Amendment to Amended and Restated Credit Agreement
Page 2
 
 
 

 

(c)           Bank shall have received a duly executed certificate of the Secretary of Borrower (i) certifying as to attached copies of Resolutions of the Board of Directors of Borrower authorizing the execution, delivery and performance of this Fifth Amendment, and (ii) certifying as complete and correct as to attached copies of the Articles of Incorporation and By-laws of Borrower or certifying that such Articles of Incorporation or By-laws have not been amended (except as shown) since the previous delivery thereof to Bank;
 
(d)           Borrower shall have paid Bank a $5,000 non-refundable fee, which is due and payable upon execution of this Fifth Amendment; and
 
(e)           All legal matters incident to this Fifth Amendment shall be reasonably satisfactory to Bank and its counsel.

PART IV.  EXPENSES

Borrower shall reimburse Bank for all reasonable legal fees and other expenses incurred by Bank in connection with this Fifth Amendment and the transactions contemplated hereby.  Bank is hereby authorized to debit Borrower’s operating account maintained at Bank for such legal fees and expenses.
 
PART V.  ADDITIONAL EXTENSION FEE

An additional extension fee owed to Bank in the amount of Thirty Thousand Dollars ($30,000) shall be fully earned and due upon execution of this Fifth Amendment; provided, however, in the event all of the Obligations under the Agreement have been paid in full and all remaining commitments of Bank under the Agreement have been terminated on or before January 15, 2010, Bank agrees to waive the payment of such additional extension fee.  Otherwise, such additional extension fee shall be payable on January 15, 2010.
 
PART VI.  COUNTERPARTS

This Fifth Amendment may be executed in counterparts, all of which taken together shall constitute one agreement.
 
[This Space Intentionally Left Blank]
   
Fifth Amendment to Amended and Restated Credit Agreement
Page 3
 
 
 

 
 
In Witness Whereof, Borrower and Bank have caused this Fifth Amendment to be executed by their respective officers duly authorized as of the date first above written.
 
Borrower
Bioanalytical Systems, Inc.
   
By:  
 
Its:
 
   
Bank
PNC Bank, National Association
   
By:
 
Its:
 
   
Fifth Amendment to Amended and Restated Credit Agreement
Page 4
 
 
 

 
-----END PRIVACY-ENHANCED MESSAGE-----